Inactivated vaccine for protection against duck virus enteritis

Avian Diseases

Volumn 41, Issue 2, 1997, Pages 461-468

  Shawky, Samia A ^a   Sandhu, T S ^a  

^a Cornell University ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANAS PLATYRHYNCHOS; ANAS SP.; ANATIDAE; ANIMALIA; AVES; DUCK ENTERITIS VIRUS; GALLUS GALLUS; HERPES; HERPESVIRIDAE;

EID: 0031127263     PISSN: 00052086     EISSN: None     Source Type: Journal    
DOI: 10.2307/1592206     Document Type: Article

References (30)

1. Allison, A. C., and N. E. Byars. An adjuvant formulation that selectively elicits the formation of antibodies of protective isotypes and cell-mediated immunity. J. Immunol. Methods 95:157-168. 1986.
2. Allison, A. C., and N. E. Byars. Immunological adjuvants desirable properties and side-effects. Mol. Immunol. 28:279-284. 1991.
3. Archetti, I., and F. L. Horsfall. Persistent antigenic variation of influenza A viruses after incomplete neutralization in ovo with heterologous immune serum. J. Exp. Med. 92:441-462. 1950.
4. Babiuk, L. A., and B. T. Rouse. Immune control of herpesvirus latency. Can. J. Microbiol. 25: 267-274. 1979.
5. Box, P. G., and I. G. S. Furminger. Newcastle disease antibody levels in chickens after vaccination with oil emulsion adjuvant killed vaccine. Vet. Rec. 96:108-111, 1975.
6. Brand, C. J., and D. E. Docherty. Post-epizootic surveys of waterfowl for duck plague (duck virus enteritis). Avian Dis. 32:722-730. 1988.
7. Brugh, M., H. D. Stone, and H. W. Lupton. Comparison of inactivated Newcastle disease viral vaccines containing different emulsion adjuvant. Am. J. Vet. Res. 44:72-75. 1983.
8. Burgess, E. C., J. Ossa, and T. M. Yuill. Duck plague: a carrier state in waterfowl. Avian Dis. 24: 940-949. 1979.
9. Burgess, E. C., and T. M. Yuill. The influence of seven environmental and physiological factors on duck plague virus shedding by carrier mallards. J. Wildl. Dis. 19:77-81. 1983.
10. Butterfield, W. K., and A. H. Dardiri. Serologie and immunologic response of ducks to inactivated and attenuated duck plague virus. Bacteriol. Proc. 100:876-887. 1969.
11. Byars, N. E., and A. C. Allison. Adjuvant formulation for use in vaccines to elicit both cell-mediated and humoral immunity. Vaccine 5:223-228. 1987.
12. Cessi, D., and L. Nardelli. Vaccination against Newcastle disease: efficacy of an oil emulsion vaccine. Avian Pathol. 3:247-253. 1974.
13. Converse, K. A., W. B. Stone, C. U. Meteryer, and D. Docherty. An outbreak of duck plague among wild waterfowl in the New York Finger Lakes. Abstract, 43rd Annual Conference of the Wild Disease Association, pp. 23-24. 1994.
14. Dardiri, A. H. Duck viral enteritis (duck plague) characteristics and immune response of the host. Am. J. Vet. Res. 36:535-538. 1975.
15. Dardiri, A. H., W. R. Hess, S. S. Breese, Jr., and H. R. Seibold. Characterization of duck plague virus from a duck disease outbreak in the United States. Proc. 39th Annual Meeting Northeastern Conf. Avian Diseases, State University of New York, Stony Brook, N. Y. June 17-20. 1967.
16. Friend, M., and G. L. Pearson. Duck plague: the present situation. Proc. Int. Assoc. State Game and Fish Commissioners, Salt Lake City, Utah. pp. 315-325. 1973.
17. Hilbind, F. W., H. L. Oei, and J. Van Roozelaar. Virulence of five live vaccines against avian infectious laryngotracheitis and their immunogenicity and spread after eye drop or spray application. Vet. Q. 9:215-225. 1987.
18. Hughes, C. S., R. A. Williams, R. M. Gaskell, F. T. W. Jordan, J. M. Bradbury, M. Bennet, and R. C. Jones. Latency and reactivation of infectious laryngotracheitis vaccine virus. Arch. Virol. 121:213-218. 1991.
19. Jackwood, D. H., and Y. M. Saif. Antigenic diversity of infectious bursal disease viruses. Avian Dis. 31:766-770. 1987.
20. Jansen, J. The interference phenomenon in the development of resistance against duck plague. J. Comp. Pathol. Therapeut. 74:3-7. 1964.
21. Kucera, C. J., R. G. White, and W. H. Bechenhauer. Evaluation of the safety and efficacy of an intranasal vaccine containing a temperature-sensitive strain of infectious bovine rhinotracheitis virus. Am. J. Vet. Res. 39:607-610. 1978.
22. Lam, K. M. Antibody and complement-mediated cytolysis against duck enteritis virus-infected cells. Avian Dis. 28:1125-1129. 1984.
23. Lam, K. M., and W. Lin. Antibody-mediated resistance against duck enteritis virus infection. Can. J. Vet. Res. 50:380-383. 1986.
24. Leibovitz, L., and J. Hwang. Duck plague on the American continent. Avian Dis. 12:361-378. 1968.
25. McKercher, D. G., and G. L. Crenshaw. Comparative efficacy of intranasally and parenterally administered infectious bovine tracheitis vaccine. J. Am. Vet. Med. Assoc. 159:1362-1369. 1971.
26. Reed, L. J., and Muench. A simple method for estimating fifty per cent endpoints. Am. J. Hyg. 27:493-496. 1938.
27. Shawky, S. A., Y. M. Saif, and D. E. Swayne. Role of circulating maternal anti-rotavirus IgG in protection of intestinal mucosal surface in turkey poults. Avian Dis. 37:1041-1050. 1993.
28. Tikoo, S. K., M. Campos, and L. A. Babiuk. Bovine herpesvirus 1(BHV-1): biology, pathogenesis, and control. Adv. Virus Res. 45:191-233. 1995.
29. Todd, J. D., F. J. Volenec, and I. M. Paton. Interferon in nasal secretions and sera of valves after intranasal administration of avirulent infectious bovine rhinotracheitis virus: association of interferon in nasal secretions with early resistance to challenge with virulent virus. Infect. Immun. 5: 699-706. 1972.
30. Toth, T. E. Active immunization of white Pekin ducks against duck virus enteritis (duck plague) with modified-live-virus vaccine: immunization of ducklings. Am. J. Vet. Res. 31:1275-1281. 1970.